表紙
市場調查報告書

癲癇:流行病學的預測

Epilepsy -Epidemiology Forecast to 2028

出版商 DelveInsight Business Research LLP 商品編碼 565332
出版日期 內容資訊 英文 50 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
癲癇:流行病學的預測 Epilepsy -Epidemiology Forecast to 2028
出版日期: 2019年01月01日內容資訊: 英文 50 Pages
簡介

本報告提供全球癲癇的流行病學的預測相關分析,在疾病概要和目前治療手法/演算法,全球整體及主要國家 (美國·歐洲各國·日本) 的患病人數趨勢預測 (總計12年份),各子類型詳細趨勢,今後的市場機會·醫藥品開發預測等相關調查。

第1章 簡介

第2章 疾病的背景情況

  • 簡介
  • 病因
  • 症狀
  • 分類
  • 風險要素
  • 診斷方法
  • 癲癇和結節性硬化症 (TSC) 突然變異
  • 目前治療方法與臨床診療

第3章 流行病學和患者人口

  • 分析的要點
  • 美國
    • 癲癇的患病人數
    • 男女的患病人數
    • 各子類型的患病人數
    • TSC (結節性硬化症) 伴隨的癲癇患病人數
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 英國
  • 日本

第4章 附錄

  • 分析方法

第5章 諮詢服務

第6章 免責聲明

第7章 關於DelveInsight

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DIEI0283

DelveInsight's "Epilepsy - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Epilepsy epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Epilepsy Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Epilepsy in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Epilepsy outlook. It also includes the explanation of changing trends of epidemiology outlining the Epilepsy scenario.

Epilepsy Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Epilepsy thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Epilepsy explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Epilepsy Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Epilepsy

Key assessments

  • Patient Segmentation in Epilepsy
  • Epilepsy Risk & Burden
  • Factors driving growth in a specific Epilepsy patient population

Table of Contents

1. Report Introduction

2. Epilepsy Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Epilepsy in 2016
  • 2.2. Patient Share Distribution of Epilepsy in 2028

3. Disease Background and Overview: Epilepsy

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Epilepsy in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Epilepsy in 7MM - By Countries

5. Epidemiology of Epilepsy by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Epilepsy
    • 5.1.3. Sub-Type Specific cases of the Epilepsy *
    • 5.1.4. Sex- Specific Cases of the Epilepsy *
    • 5.1.5. Diagnosed Cases of the Epilepsy
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Epilepsy
    • 5.4.3. Sub-Type Specific cases of the Epilepsy *
    • 5.4.4. Sex- Specific Cases of the Epilepsy *
    • 5.4.5. Diagnosed Cases of the Epilepsy
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Epilepsy
    • 5.5.3. Sub-Type Specific cases of the Epilepsy *
    • 5.5.4. Sex- Specific Cases of the Epilepsy *
    • 5.5.5. Diagnosed Cases of the Epilepsy
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Epilepsy
    • 5.6.3. Sub-Type Specific cases of the Epilepsy *
    • 5.6.4. Sex- Specific Cases of the Epilepsy *
    • 5.6.5. Diagnosed Cases of the Epilepsy
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Epilepsy
    • 5.7.3. Sub-Type Specific cases of the Epilepsy *
    • 5.7.4. Sex- Specific Cases of the Epilepsy *
    • 5.7.5. Diagnosed Cases of the Epilepsy
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Epilepsy
    • 5.8.3. Sub-Type Specific cases of the Epilepsy *
    • 5.8.4. Sex- Specific Cases of the Epilepsy *
    • 5.8.5. Diagnosed Cases of the Epilepsy
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Epilepsy
    • 5.9.3. Sub-Type Specific cases of the Epilepsy *
    • 5.9.4. Sex- Specific Cases of the Epilepsy *
    • 5.9.5. Diagnosed Cases of the Epilepsy

6. Unmet Needs of the Epilepsy

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Epilepsy in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Epilepsy in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Epilepsy in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Epilepsy in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Epilepsy in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Epilepsy in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Epilepsy in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Epilepsy in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Epilepsy in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Epilepsy in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Epilepsy in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Epilepsy in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Epilepsy in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Epilepsy in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Epilepsy in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Epilepsy in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Epilepsy in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Epilepsy in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Epilepsy in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Epilepsy in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Epilepsy in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Epilepsy in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Epilepsy in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Epilepsy in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Epilepsy in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Epilepsy in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Epilepsy in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Epilepsy in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Epilepsy in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Epilepsy in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Epilepsy in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Epilepsy in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Epilepsy in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Epilepsy in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Epilepsy in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Epilepsy in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Epilepsy in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Epilepsy in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Epilepsy in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Epilepsy in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Epilepsy in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Epilepsy in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Epilepsy in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Epilepsy in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Epilepsy in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Epilepsy in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Epilepsy in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Epilepsy in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Epilepsy in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Epilepsy in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Epilepsy in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Epilepsy in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Epilepsy in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Epilepsy in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Epilepsy in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Epilepsy in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Epilepsy in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Epilepsy in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Epilepsy in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Epilepsy in Japan (2016-2028)
Back to Top